These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 9210850
1. [Treatment with the implantable cardioverter defibrillator (ICD)]. Jordaens LJ. Verh K Acad Geneeskd Belg; 1997; 59(2):107-33. PubMed ID: 9210850 [Abstract] [Full Text] [Related]
3. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S, Kasanuki H. J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174 [Abstract] [Full Text] [Related]
4. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH, ALPHEE Study Investigators. Circulation; 2011 Dec 13; 124(24):2649-60. PubMed ID: 22082672 [Abstract] [Full Text] [Related]
14. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, Igidbashian D, Raviele A, Disertori M, Zanotto G, Verlato R, Vergara G, Delise P, Turrini P, Basso C, Naccarella F, Maddalena F, Estes NA, Buja G, Thiene G. Circulation; 2003 Dec 23; 108(25):3084-91. PubMed ID: 14638546 [Abstract] [Full Text] [Related]
15. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death. Akhtar M, Jazayeri MR, Sra JS, Dhala A, Deshpande S, Blanck Z, Axtell K. Cardiol Clin; 1993 Feb 23; 11(1):97-108. PubMed ID: 8435827 [Abstract] [Full Text] [Related]
16. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697 [Abstract] [Full Text] [Related]
17. Secondary prevention of sudden cardiac death. Curnis A, Mascioli G, Bontempi L, Bordonali T, Dei Cas L. Ital Heart J; 2005 Mar 08; 6(3):216-20. PubMed ID: 15875512 [Abstract] [Full Text] [Related]